Abnormal Th1 and Th17 cell responses to gut microbiota, which have been shown to contribute to the pathogenesis of IBD [5–7], are controlled by several mechanisms, including T cell-producing interleukin 10 (IL-10) and IL-22. The gene discussed is IL22; the disease is inflammatory bowel disease.